A model for harmonizing flow cytometry in clinical trials
- 19 October 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Immunology
- Vol. 11 (11), 975-978
- https://doi.org/10.1038/ni1110-975
Abstract
Complexities in sample handling, instrument setup and data analysis are barriers to the effective use of flow cytometry to monitor immunological parameters in clinical trials. The novel use of a central laboratory may help mitigate these issues.Keywords
This publication has 24 references indexed in Scilit:
- “MIATA”—Minimal Information about T Cell AssaysImmunity, 2009
- Optimization and Limitations of Use of Cryopreserved Peripheral Blood Mononuclear Cells for Functional and Phenotypic T-Cell CharacterizationClinical and Vaccine Immunology, 2009
- A Prescription for Human ImmunologyImmunity, 2008
- Sleep-dependent activity of T cells and regulatory T cellsClinical and Experimental Immunology, 2008
- MIFlowCyt: The minimum information about a flow cytometry experimentCytometry Part A, 2008
- Toward quantitative fluorescence measurements with multicolor flow cytometryCytometry Part A, 2007
- Evidence supporting a circadian control of natural killer cell functionBrain, Behavior, and Immunity, 2006
- Seventeen-colour flow cytometry: unravelling the immune systemNature Reviews Immunology, 2004
- Ethyleneglycol-Bis-(β-Aminoethylether)Tetraacetate as a Blood Anticoagulant: Preservation of Antigen-Presenting Cell Function and Antigen-Specific Proliferative Response of Peripheral Blood Mononuclear Cells from Stored BloodClinical and Diagnostic Laboratory Immunology, 2000
- Seasonal modulation of the circadian time structure of circulating T and natural killer lymphocyte subsets from healthy subjects.JCI Insight, 1988